西点药业(301130.SZ)发布前三季度业绩，归母净利润3314.64万元，下降2.7%

Core Insights - West Point Pharmaceutical (301130.SZ) reported a revenue of 189 million yuan for the first three quarters of 2025, representing a year-on-year decrease of 1.89% [1] - The net profit attributable to shareholders of the listed company was 33.1464 million yuan, down 2.70% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 29.8086 million yuan, showing a year-on-year increase of 3.19% [1] - The basic earnings per share were 0.4333 yuan [1]